Mice expressing constitutively active Gsα exhibit stimulus encoding deficits similar to those observed in schizophrenia patients

被引:13
作者
Maxwell, C. R.
Liang, Y.
Kelly, M. P.
Kanes, S. J.
Abel, T.
Siegel, S. J.
机构
[1] Univ Penn, Dept Psychiat, Div Neuropsychiat, Translat Res Labs, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA
关键词
G(s)alpha; N40; schizophrenia; cAMP; haloperidol; event-related potentials;
D O I
10.1016/j.neuroscience.2006.04.028
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
People with schizophrenia display sensory encoding deficits across a broad range of electrophysiological and behavioral measures, suggesting fundamental impairments in the ability to transduce the external environment into coherent neural representations. This inability to create basic components of complex stimuli interferes with a high fidelity representation of the world and likely contributes to cognitive deficits. The current study evaluates the effects of constitutive forebrain activation of the G(s)alpha G-protein subunit on auditory threshold and gain using acoustic brainstem responses and cortically generated N40 event-related potentials to assess the role of cyclic AMP signaling in sensory encoding. Additionally, we examine the ability of pharmacological treatments that mimic (amphetamine) or ameliorate (haloperidol) positive symptoms of schizophrenia to test the hypothesis that the encoding deficits observed in G(s)alpha transgenic mice can be normalized with treatment. We find that Gsa transgenic mice have decreased amplitude of cortically generated N40 but normal acoustic brainstem response amplitude, consistent with forebrain transgene expression and a schizophrenia endophenotype. Transgenic mice also display decreased stimulus intensity response (gain) in both acoustic brainstem response and N40, indicating corticofugal influence on regions that lack transgene expression. N40 deficits in transgenic animals were ameliorated with low dose haloperidol and reversed with higher dose, suggesting dopamine D-2 receptor-linked G, activity contributes to the impairment. Consistent with this hypothesis, we recreated the Gsa transgenic deficit in wild type animals using the indirect dopamine agonist amphetamine. This transgenic model of sensory encoding deficits provides a foundation for identifying biochemical contributions to sensory processing impairments associated with schizophrenia. (c) 2006 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1257 / 1264
页数:8
相关论文
共 24 条
  • [1] Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-based long-term memory
    Abel, T
    Nguyen, PV
    Barad, M
    Deuel, TAS
    Kandel, ER
    [J]. CELL, 1997, 88 (05) : 615 - 626
  • [2] NEUROPHYSIOLOGICAL STUDIES OF SENSORY GATING IN RATS - EFFECTS OF AMPHETAMINE, PHENCYCLIDINE, AND HALOPERIDOL
    ADLER, LE
    ROSE, G
    FREEDMAN, R
    [J]. BIOLOGICAL PSYCHIATRY, 1986, 21 (8-9) : 787 - 798
  • [3] Sensory gating deficits during the mid-latency phase of information processing in medicated schizophrenia patients
    Boutros, NN
    Korzyukov, O
    Jansen, B
    Feingold, A
    Bell, M
    [J]. PSYCHIATRY RESEARCH, 2004, 126 (03) : 203 - 215
  • [4] Inhibition of auditory evoked potentials and prepulse inhibition of startle in DBA/2J and DBA/2Hsd inbred mouse substrains
    Connolly, PM
    Maxwell, CR
    Kanes, SJ
    Abel, T
    Liang, YL
    Tokarczyk, J
    Bilker, WB
    Turetsky, BI
    Gur, RE
    Siegel, SJ
    [J]. BRAIN RESEARCH, 2003, 992 (01) : 85 - 95
  • [5] The effects of ketamine vary among inbred mouse strains and mimic schizophrenia for the P80, but not P20 or N40 auditory ERP components
    Connolly, PM
    Maxwell, C
    Liang, YL
    Kahn, JB
    Kanes, SJ
    Abel, T
    Gur, RE
    Turetsky, BI
    Siegel, SJ
    [J]. NEUROCHEMICAL RESEARCH, 2004, 29 (06) : 1179 - 1188
  • [6] Reduced Gi and Go protein function in the rat nucleus accumbens attenuates sensorimotor gating deficits
    Culm, KE
    Lim, AM
    Onton, JA
    Hammer, RP
    [J]. BRAIN RESEARCH, 2003, 982 (01) : 12 - 18
  • [7] Glickstein M., 1976, HISTOLOGICAL PROCESS
  • [8] Sensorimotor gating deficits in transgenic mice expressing a constitutively active form of Gsα
    Gould, TJ
    Bizily, SP
    Tokarczyk, J
    Kelly, MP
    Siegel, SJ
    Kanes, SJ
    Abel, T
    [J]. NEUROPSYCHOPHARMACOLOGY, 2004, 29 (03) : 494 - 501
  • [9] HENRY KR, 1979, AUDIOLOGY, V18, P93
  • [10] Human and animal studies of schizophrenia-related gating deficits.
    Light G.A.
    Braff D.L.
    [J]. Current Psychiatry Reports, 1999, 1 (1) : 31 - 40